US equities
|
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MSFT
$530.14
▼-0.16%
MU
$934.27
▼-4.98%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
GOOGL
$283.82
▼-12.64%
GOOG
$282.32
▼-12.29%
MSFT
$530.14
▼-0.16%
MU
$934.27
▼-4.98%
AMZN
$243.79
▼-4.25%
META
$624.52
▲+1.96%
NVDA
$213.66
▼-0.80%
AAPL
$348.91
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
9.560
-5.250 (-35.45%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Continues Lead Plaintiff Search for Iovance Biotherapeutics, Inc. (IOVA) Securities Fraud Class Action
May 20, 2025
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?
↗
May 20, 2025
Via
The Motley Fool
Deadline Approaching: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
May 20, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
IOVA BREAKING NEWS: Iovance Biotherapeutics, Inc. Stock Plummets 44% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:IOVA)
May 20, 2025
From
Bleichmar Fonti & Auld LLP
Via
Business Wire
Law Offices of Frank R. Cruz Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors To Inquire About Securities Fraud Class Action
May 19, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Deadline Alert: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
May 19, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Kaplan Fox Encourages Investors of Iovance Biotherapeuitcs, Inc. (IOVA) to Contact the Firm Before Lead Plaintiff Deadline on July 14, 2025
May 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Encourages Investors of Iovance Biotherapeuitcs, Inc. (IOVA) to Contact the Firm Before Lead Plaintiff Deadline on July 14, 2025
May 19, 2025
Via
TheNewswire.com
Topics
Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
May 18, 2025
From
Pomerantz LLP
Via
GlobeNewswire
IOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
May 18, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Kaplan Fox Alerts Investors of Iovance Biotherapeutics, Inc. (IOVA) to a Securities Class Action Deadline on July 14, 2025
May 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Alerts Investors of Iovance Biotherapeutics, Inc. (IOVA) to a Securities Class Action Deadline on July 14, 2025
May 17, 2025
Via
TheNewswire.com
Topics
Lawsuit
FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues Lead Plaintiff Search for Iovance Biotherapeutics, Inc. (IOVA) Securities Fraud Class Action
May 16, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
IOVANCE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Iovance Biotherapeutics, Inc. and Encourages Investors to Contact the Firm
May 16, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Why Iovance Biotherapeutics Tumbled by Nearly 6% Today
↗
May 16, 2025
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 16, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Kaplan Fox Alerts Investors to a Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Deadline is July 14, 2025
May 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Alerts Investors to a Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Deadline is July 14, 2025
May 16, 2025
Via
TheNewswire.com
Topics
Lawsuit
Law Offices of Howard G. Smith Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors to Inquire About Securities Fraud Class Action
May 16, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
May 16, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Rosen Law Firm Urges Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
May 16, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
This Foot Locker Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
↗
May 16, 2025
Via
Benzinga
IOVA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Iovance Biotherapeutics, Inc.
May 16, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
IOVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Iovance Biotherapeutics, Inc. Investors
May 16, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Iovance Biotherapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - IOVA
May 15, 2025
From
DJS Law Group
Via
Business Wire
Kaplan Fox is Investigating Potential Securities Law Violations Against Iovance Biotherapeutics, Inc. (IOVA)
May 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox is Investigating Potential Securities Law Violations Against Iovance Biotherapeutics, Inc. (IOVA)
May 15, 2025
Via
TheNewswire.com
Is This Beaten-Down Stock a Buy Near Its 52-Week Low?
↗
May 15, 2025
Via
The Motley Fool
IOVANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Iovance Biotherapeutics, Inc. on Behalf of Iovance Stockholders and Encourages Investors to Contact the Firm
May 13, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kaplan Fox Announces an Investigation Into Iovance Biotherapeutics, Inc. (IOVA) for Potential Securities Law Violations
May 13, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
